20 May 2013
Keywords: emea, agrees, strategy, spectrum, eoquin, cancer, drug
Article | 14 January 2008
US cancer drug specialist Spectrum Pharmaceuticals has received notice
from the European Medicines Agency (EMEA) that it agrees with the
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
15 October 2007
20 August 2007
17 May 2013
© 2013 thepharmaletter.com